120 related articles for article (PubMed ID: 16420586)
1. A new method for assessment of an anti-5HT(2A) agent, sarpogrelate hydrochloride, on platelet aggregation.
Satoh K; Yatomi Y; Ozaki Y
J Thromb Haemost; 2006 Feb; 4(2):479-81. PubMed ID: 16420586
[No Abstract] [Full Text] [Related]
2. Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin.
Nakamura K; Kariyazono H; Moriyama Y; Toyohira H; Kubo H; Yotsumoto G; Taira A; Yamada K
Blood Coagul Fibrinolysis; 1999 Dec; 10(8):513-9. PubMed ID: 10636463
[TBL] [Abstract][Full Text] [Related]
3. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
4. Effects of sarpogrelate hydrochloride on adenosine diphosphate- or collagen-induced platelet responses in arteriosclerosis obliterans.
Nakamura K; Kariyazono H; Masuda H; Sakata R; Yamada K
Blood Coagul Fibrinolysis; 2001 Jul; 12(5):391-7. PubMed ID: 11505083
[TBL] [Abstract][Full Text] [Related]
5. Quantitative measurement of various 5-HT receptor antagonists on platelet activation induced by serotonin.
Qi R; Ozaki Y; Satoh K; Kurota K; Asazuma N; Yatomi Y; Kume S
Thromb Res; 1996 Jan; 81(1):43-54. PubMed ID: 8747519
[TBL] [Abstract][Full Text] [Related]
6. The effect of MCI-9042 on serotonin-induced platelet aggregation in type 2 diabetes mellitus.
Pietraszek MH; Takada Y; Taminato A; Yoshimi T; Watanabe I; Takada A
Thromb Res; 1993 Apr; 70(2):131-8. PubMed ID: 8322284
[TBL] [Abstract][Full Text] [Related]
7. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
[TBL] [Abstract][Full Text] [Related]
8. Anti-aggregation effect of aroxyalkyl derivatives of 2-methoxyphenylpiperazine is due to their 5-HT
Kubacka M; Kazek G; Kotańska M; Filipek B; Waszkielewicz AM; Mogilski S
Eur J Pharmacol; 2018 Jan; 818():263-270. PubMed ID: 29111111
[TBL] [Abstract][Full Text] [Related]
9. The 5-hydroxytryptamine2A receptor antagonist sarpogrelate hydrochloride inhibits acute platelet aggregation in injured endothelium.
Houkin K; Nakayama N; Nonaka T; Koyanagi I
J Int Med Res; 2006; 34(1):65-72. PubMed ID: 16604825
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte-protective effect of sarpogrelate hydrochloride (Anplag ®), a selective 5-HT2 receptor antagonist: an in vitro study.
Nakamura K; Kawahito K
J Artif Organs; 2010 Sep; 13(3):178-81. PubMed ID: 20799047
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
[TBL] [Abstract][Full Text] [Related]
12. Exploring the antiplatelet activity of serotonin 5-HT
Marcinkowska M; Kubacka M; Zagorska A; Jaromin A; Fajkis-Zajaczkowska N; Kolaczkowski M
Biomed Pharmacother; 2022 Jan; 145():112424. PubMed ID: 34785417
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic analysis of antiplatelet effect of sarpogrelate hydrochloride and its application to drug dosage regimen--modeling based on reversible inhibition of 5-HT2 serotonergic receptor in the platelet membrane by sarpogrelate hydrochloride and its metabolite].
Shimizu T; Yamada Y; Tashita A; Yamamoto K; Kotaki H; Sawada Y; Iga T
Yakugaku Zasshi; 1999 Nov; 119(11):850-60. PubMed ID: 10590712
[TBL] [Abstract][Full Text] [Related]
14. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood.
Sanderson HM; Heptinstall S; Vickers J; Lösche W
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):245-8. PubMed ID: 8735830
[TBL] [Abstract][Full Text] [Related]
15. Electroencephalographical effects of sarpogrelate hydrochloride versus ticlopidine hydrochloride in elderly patients with peripheral atherosclerosis.
Iwakuma H
J Int Med Res; 2004; 32(3):274-83. PubMed ID: 15174221
[TBL] [Abstract][Full Text] [Related]
16. Collagen induced human platelet aggregation: serotonin receptor antagonism retards aggregate growth in vitro.
Menys VC
Cardiovasc Res; 1993 Nov; 27(11):1916-9. PubMed ID: 8287397
[TBL] [Abstract][Full Text] [Related]
17. Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor.
Muntasir HA; Bhuiyan MA; Ishiguro M; Ozaki M; Nagatomo T
J Pharmacol Sci; 2006 Oct; 102(2):189-95. PubMed ID: 17031071
[TBL] [Abstract][Full Text] [Related]
18. Effects of sarpogrelate on serotonin-induced increases in cytosolic Ca2+ in cultured rat mesangial cells.
Kanamori A; Matoba K; Yajima Y
Life Sci; 1994; 55(18):PL365-70. PubMed ID: 7934648
[TBL] [Abstract][Full Text] [Related]
19. The effect of a 5HT2 receptor antagonist sarpogrelate (MCI-9042) treatment on platelet function in Buerger's disease.
Rydzewski A; Urano T; Hachiya T; Kaneko H; Baba S; Takada Y; Takada A
Thromb Res; 1996 Dec; 84(6):445-52. PubMed ID: 8987165
[TBL] [Abstract][Full Text] [Related]
20. Urapidil inhibits 5-hydroxytryptamine induced platelet aggregation and 14C-5-hydroxytryptamine uptake in platelets.
Storck J; Kirsten R
Curr Med Res Opin; 1990; 12(2):86-92. PubMed ID: 2390867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
